跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 155 条关于
“CPS1”
全部
155
临床试验
86
药物
45
机构
1
资讯
23
去年
First-of-its-kind Gene Editing Treatment Saves Baby with Rare Genetic Disorder
11个月前
Researchers Plan FDA Application for Groundbreaking CRISPR Base Editing Trial Following Baby KJ's Successful Treatment
9个月前
First-Ever Personalized CRISPR Therapy Successfully Treats Baby with Ultra-Rare Metabolic Disorder
去年
Breakthrough: First Personalized mRNA-Based CRISPR Therapy Successfully Treats Infant with Rare Metabolic Disorder
去年
NIH Grant Funds Gene-Editing Research for Rare Metabolic Disorders
去年
CRISPR Gene Editing Breakthrough Saves Baby with Ultra-Rare Metabolic Disorder
去年
IDT Launches HDR Enhancer Protein to Boost CRISPR Gene Editing Efficiency in Therapeutic Applications
8个月前
FDA Announces Flexible Manufacturing Requirements for Cell and Gene Therapies to Accelerate Innovation
上个月
Genomic Profiling of High-Risk Pediatric Tumors Reveals Actionable Alterations in Nearly One-Quarter of Patients
去年
Nanostics Secures CPSA Accreditation for Relocated Prostate Cancer Diagnostic Lab in Edmonton
第 1 页,共 3 页
上一页
下一页